The short fiber knobs of human adenovirus in species F elicit cross-neutralizing antibody responses

被引:1
|
作者
Liu, Zhenwei [1 ,2 ,3 ]
Tang, Guolu [1 ,2 ]
Peng, Yinghui [1 ,2 ]
Lan, Jixian [4 ]
Xian, Yuting [4 ]
Tian, Xingui [3 ]
Chen, Dehui [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou, Peoples R China
[2] Guangzhou Med Univ, State Key Lab Resp Dis, Guangdong Hong Kong Macao Joint Lab Resp Infect Di, Guangzhou, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China
[4] Guangdong Sanmai Biotechnol Co Ltd, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Human adenovirus type 40 and 41; Short fiber knob; Cross-neutralization; MOLECULAR CHARACTERIZATION; ACUTE GASTROENTERITIS; CHILDREN; IDENTIFICATION; RECEPTOR; TRANSMISSION; DIARRHEA; VECTORS; HEXON; AGE;
D O I
10.1016/j.heliyon.2024.e35783
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human adenovirus (HAdV) type 40 in species F (HAdV-F40) and HAdV-F41 represent the third most prevalent causative agents of non-bacterial acute gastroenteritis in infants and young children, following norovirus and rotavirus. Despite their significant contribution to global child morbidity, vaccines to preemptively combat these viruses remain elusive. In this study, we investigate the potential for cross-neutralization between HAdV-F40 and HAdV-F41 using immune sera with the short fiber knob (SFK). We implemented a series of assays to evaluate the responses, including enzyme-linked immunosorbent, micro-neutralization, immunofluorescence, and quantitative polymerase chain reaction. Our results demonstrate that immune sera with HAdV-F40 SFK or HAdV-F41 SFK could effectively neutralize both HAdV-F40 and HAdV-F41, indicating a mutual cross-neutralizing effect. Notably, the immune sera with HAdV-F40 SFK demonstrated a stronger neutralization effect, suggesting the potential to develop a subunit vaccine that can simultaneously counteract both viruses. These findings underscore the potential of SFK immunization in evoking a cross-neutralizing antibody response between HAdV-F40 and HAdV-F41. This suggests a promising avenue for developing subunit vaccines against HAdV-F40 and HAdV-F41 and provides a novel perspective on the potential of neutralizing antibodies to protect against these two types of HAdV.
引用
收藏
页数:12
相关论文
共 41 条
  • [21] Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection
    Flyak, Andrew I.
    Shen, Xiaoli
    Murin, Charles D.
    Turner, Hannah L.
    David, Joshua A.
    Fusco, Marnie L.
    Lampley, Rebecca
    Kose, Nurgun
    Ilinykh, Philipp A.
    Kuzmina, Natalia
    Branchizio, Andre
    King, Hannah
    Brown, Leland
    Bryan, Christopher
    Davidson, Edgar
    Doranz, Benjamin J.
    Slaughter, James C.
    Sapparapu, Gopal
    Klages, Curtis
    Ksiazek, Thomas G.
    Saphire, Erica Ollmann
    Ward, Andrew B.
    Bukreyev, Alexander
    Crowe, James E., Jr.
    CELL, 2016, 164 (03) : 392 - 405
  • [22] Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses (vol 14, 3713, 2023)
    Hellgren, Fredrika
    Cagigi, Alberto
    Cerveira, Rodrigo Arcoverde
    Ols, Sebastian
    Kern, Theresa
    Lin, Ang
    Eriksson, Bengt
    Dodds, Michael G.
    Jasny, Edith
    Schwendt, Kim
    Freuling, Conrad
    Mueller, Thomas
    Corcoran, Martin
    Hedestam, Gunilla Karlsson B.
    Petsch, Benjamin
    Lore, Karin
    Usa, Certara
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [23] Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
    Mariz, Filipe Colaco
    Bender, Noemi
    Anantharaman, Devasena
    Basu, Partha
    Bhatla, Neerja
    Pillai, Madhavan Radhakrisna
    Prabhu, Priya R.
    Sankaranarayanan, Rengaswamy
    Eriksson, Tiina
    Pawlita, Michael
    Prager, Kristina
    Sehr, Peter
    Waterboer, Tim
    Mueller, Martin
    Lehtinen, Matti
    NPJ VACCINES, 2020, 5 (01)
  • [24] Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
    Filipe Colaço Mariz
    Noemi Bender
    Devasena Anantharaman
    Partha Basu
    Neerja Bhatla
    Madhavan Radhakrisna Pillai
    Priya R. Prabhu
    Rengaswamy Sankaranarayanan
    Tiina Eriksson
    Michael Pawlita
    Kristina Prager
    Peter Sehr
    Tim Waterboer
    Martin Müller
    Matti Lehtinen
    npj Vaccines, 5
  • [25] Cross-neutralizing human monoclonal anti-HIV-1 antibody 2F5:: Preparation and crystallographic analysis of the free and epitope-complexed forms of its Fab′ fragment
    Bryson, S
    Cunningham, A
    Ho, J
    Hynes, RC
    Isenman, DE
    Barber, BH
    Kunert, R
    Katinger, H
    Klein, M
    Pai, EF
    PROTEIN AND PEPTIDE LETTERS, 2001, 8 (05): : 413 - 418
  • [26] Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: Evidence of highly cross-neutralizing antibody responses in early patient sera
    Lundkvist, A
    Hukic, M
    Horling, J
    Gilljam, M
    Nichol, S
    Niklasson, B
    JOURNAL OF MEDICAL VIROLOGY, 1997, 53 (01) : 51 - 59
  • [27] Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice
    Seo, Sang Hwan
    Choi, Jung-ah
    Jung, Dae-Im
    Park, Yunjeong
    Yang, Eunji
    Jung, Seohee
    Kwon, Taesoo
    Kwon, Soon-Hwan
    Song, Manki
    VIROLOGY JOURNAL, 2024, 21 (01)
  • [28] Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice
    Chen, Xue
    Zhang, Ting
    Liu, Hongyang
    Hao, Yaru
    Liao, Guoyang
    Xu, Xuemei
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) : 2025 - 2033
  • [29] Crystal structure of the complex between the Fab′ fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the Fab fragment of its anti-idiotypic antibody 3H6
    Bryson, Steve
    Julien, Jean-Philippe
    Isenman, David E.
    Kunert, Renate
    Katinger, Hermann
    Pai, Emil F.
    JOURNAL OF MOLECULAR BIOLOGY, 2008, 382 (04) : 910 - 919
  • [30] Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal neutralizing antibodies contribute to sequential infection with these viruses in childhood
    Yoshida, M
    Torigoe, S
    Ikeue, K
    Yamada, M
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (02) : 388 - 393